Crinetics Pharmaceuticals, Inc.
CRNX
Cena:
$ 36.80
-0.29 (-0.78%)
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| FMR LLC | 15.8 mil | 16.76% | 0.00% | 0.03% | 2018-09-30 |
| VANGUARD GROUP INC | 9.1 mil | 9.70% | 0.00% | 0.01% | 2018-09-30 |
| BLACKROCK FUNDING, INC. /DE | 7.5 mil | 9.38% | 0.00% | 0.01% | 2024-09-30 |
| BLACKROCK, INC. | 8.5 mil | 9.01% | 0.00% | 0.01% | 2024-09-30 |
| FARALLON CAPITAL MANAGEMENT LLC | 8.3 mil | 8.86% | 0.26% | 1.73% | 2023-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.2 mil | 8.67% | -0.01% | 0.06% | 2020-06-30 |
| BLACKROCK INC. | 6.2 mil | 8.62% | 0.00% | 0.01% | 2018-09-30 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 6.4 mil | 6.80% | -0.31% | 1.71% | 2020-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.4 mil | 5.69% | 0.00% | 0.02% | 2018-09-30 |
| 4.6 mil | 4.93% | 0.01% | 0.01% | 2026-03-31 | |
| JANUS HENDERSON GROUP PLC | 4.5 mil | 4.81% | -0.01% | 0.08% | 2022-09-30 |
| ECOR1 CAPITAL, LLC | 4.3 mil | 4.56% | -2.45% | 6.61% | 2021-12-31 |
| BELLEVUE GROUP AG | 3.3 mil | 3.49% | 2.83% | 2.84% | 2025-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5 mil | 2.64% | 0.00% | 0.01% | 2018-09-30 |
| STATE STREET CORP | 2.4 mil | 2.55% | 0.00% | 0.00% | 2018-09-30 |
| BAKER BROS. ADVISORS LP | 2.4 mil | 2.50% | 0.04% | 0.49% | 2025-06-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.3 mil | 2.48% | -0.02% | 0.12% | 2019-09-30 |
| PARADIGM BIOCAPITAL ADVISORS LP | 2.2 mil | 2.35% | -0.39% | 2.63% | 2022-09-30 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.9 mil | 2.06% | 0.05% | 0.05% | 2023-03-31 |
| SIREN, L.L.C. | 1.9 mil | 2.02% | -0.18% | 1.92% | 2024-09-30 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.9 mil | 2.00% | 0.00% | 0.07% | 2023-12-31 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.7 mil | 1.82% | 0.00% | 0.07% | 2022-09-30 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.6 mil | 1.72% | -0.08% | 0.52% | 2023-03-31 |
| NOVO HOLDINGS A/S | 1.6 mil | 1.65% | -1.31% | 4.56% | 2022-03-31 |
| RTW INVESTMENTS, LP | 1.5 mil | 1.54% | -0.11% | 0.52% | 2025-06-30 |
| ARTAL GROUP S.A. | 1.1 mil | 1.47% | -0.44% | 1.22% | 2024-03-31 |
| JPMORGAN CHASE & CO | 1.3 mil | 1.41% | 0.00% | 0.00% | 2018-09-30 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.1 mil | 1.21% | 1.38% | 2.44% | 2024-06-30 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 1.1 mil | 1.16% | -0.70% | 3.55% | 2021-12-31 |
| AMERICAN CENTURY COMPANIES INC | 1.1 mil | 1.12% | -0.01% | 0.02% | 2023-06-30 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1.0 mil | 1.11% | 0.97% | 0.97% | 2026-03-31 |
| ORBIMED ADVISORS LLC | 999.00 tis | 1.06% | -0.23% | 0.72% | 2018-09-30 |
| MORGAN STANLEY | 919.69 tis | 0.98% | 0.00% | 0.00% | 2018-09-30 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 907.41 tis | 0.96% | -0.13% | 0.33% | 2024-06-30 |
| JENNISON ASSOCIATES LLC | 904.67 tis | 0.96% | -0.01% | 0.02% | 2023-06-30 |
| AVIDITY PARTNERS MANAGEMENT LP | 529.00 tis | 0.93% | -0.04% | 0.69% | 2023-09-30 |
| DIMENSIONAL FUND ADVISORS LP | 852.26 tis | 0.91% | 0.00% | 0.01% | 2020-12-31 |
| PERCEPTIVE ADVISORS LLC | 724.70 tis | 0.90% | -0.79% | 0.78% | 2018-09-30 |
| LORD, ABBETT & CO. LLC | 724.63 tis | 0.90% | 0.00% | 0.12% | 2023-12-31 |
| NORTHERN TRUST CORP | 841.30 tis | 0.89% | 0.00% | 0.00% | 2018-09-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 833.42 tis | 0.89% | 0.00% | 0.00% | 2018-09-30 |
| CANDRIAM S.C.A. | 830.96 tis | 0.88% | -0.04% | 0.16% | 2025-03-31 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 632.13 tis | 0.87% | 0.06% | 0.06% | 2024-03-31 |
| ABRDN PLC | 820.40 tis | 0.87% | 0.00% | 0.05% | 2023-12-31 |
| AMERIPRISE FINANCIAL INC | 798.33 tis | 0.85% | 0.00% | 0.01% | 2024-06-30 |
| FISHER ASSET MANAGEMENT, LLC | 762.70 tis | 0.81% | 0.00% | 0.01% | 2022-09-30 |
| VESTAL POINT CAPITAL, LP | 750.00 tis | 0.80% | -0.86% | 1.41% | 2024-09-30 |
| BANK OF AMERICA CORP /DE/ | 716.13 tis | 0.76% | 0.00% | 0.00% | 2018-09-30 |
| EVENTIDE ASSET MANAGEMENT, LLC | 609.01 tis | 0.76% | -0.08% | 0.57% | 2023-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 708.47 tis | 0.75% | 0.01% | 0.01% | 2026-03-31 |
| MARSHALL WACE, LLP | 684.11 tis | 0.73% | 0.02% | 0.02% | 2026-03-31 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 397.48 tis | 0.70% | -2.38% | 0.76% | 2022-03-31 |
| FRANKLIN RESOURCES INC | 649.14 tis | 0.69% | 0.00% | 0.00% | 2023-03-31 |
| GOLDMAN SACHS GROUP INC | 628.16 tis | 0.67% | 0.00% | 0.00% | 2020-06-30 |
| SATURN V CAPITAL MANAGEMENT LLC | 479.68 tis | 0.66% | -4.27% | 8.12% | 2022-12-31 |
| NUVEEN ASSET MANAGEMENT, LLC | 527.79 tis | 0.66% | 0.00% | 0.01% | 2019-06-30 |
| FIERA CAPITAL CORP | 589.65 tis | 0.63% | -0.01% | 0.07% | 2024-03-31 |
| UBS GROUP AG | 571.90 tis | 0.61% | 0.00% | 0.00% | 2018-09-30 |
| NUVEEN, LLC | 551.46 tis | 0.59% | 0.00% | 0.01% | 2025-03-31 |
| AFFINITY ASSET ADVISORS, LLC | 460.00 tis | 0.57% | 0.36% | 3.15% | 2023-09-30 |
| FIRST TURN MANAGEMENT, LLC | 453.38 tis | 0.57% | 1.29% | 4.15% | 2024-06-30 |
| SG AMERICAS SECURITIES, LLC | 522.27 tis | 0.56% | -0.06% | 0.06% | 2024-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 445.95 tis | 0.56% | -0.03% | 0.13% | 2023-03-31 |
| LAURION CAPITAL MANAGEMENT LP | 350.77 tis | 0.49% | -0.06% | 0.19% | 2023-09-30 |
| VIVO CAPITAL, LLC | 350.00 tis | 0.48% | 0.27% | 1.29% | 2023-09-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 429.06 tis | 0.46% | 0.00% | 0.02% | 2023-03-31 |
| BIOIMPACT CAPITAL LLC | 428.98 tis | 0.46% | -1.51% | 2.14% | 2021-09-30 |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 425.62 tis | 0.45% | 0.00% | 0.03% | 2024-12-31 |
| CAPTION MANAGEMENT, LLC | 319.00 tis | 0.44% | 0.19% | 0.23% | 2023-09-30 |
| WALLEYE CAPITAL LLC | 315.22 tis | 0.44% | 0.01% | 0.03% | 2021-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 398.40 tis | 0.42% | 0.00% | 0.00% | 2025-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 382.36 tis | 0.41% | 0.00% | 0.01% | 2024-12-31 |
| STEMPOINT CAPITAL LP | 317.06 tis | 0.40% | 0.78% | 4.05% | 2023-12-31 |
| IKARIAN CAPITAL, LLC | 368.50 tis | 0.39% | 1.34% | 1.34% | 2025-12-31 |
| DUQUESNE FAMILY OFFICE LLC | 309.00 tis | 0.39% | 0.06% | 0.53% | 2024-03-31 |
| BANK OF NEW YORK MELLON CORP | 358.72 tis | 0.38% | 0.00% | 0.00% | 2018-09-30 |
| LOGOS GLOBAL MANAGEMENT LP | 350.00 tis | 0.38% | 2.09% | 2.09% | 2025-03-31 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 300.00 tis | 0.37% | -0.42% | 1.31% | 2023-09-30 |
| INVESCO LTD. | 298.25 tis | 0.37% | 0.00% | 0.00% | 2021-06-30 |
| PROSIGHT MANAGEMENT, LP | 350.00 tis | 0.37% | -0.44% | 2.08% | 2025-06-30 |
| IMPAX ASSET MANAGEMENT GROUP PLC | 350.00 tis | 0.37% | 0.01% | 0.09% | 2025-12-31 |
| CITIGROUP INC | 248.05 tis | 0.37% | 0.01% | 0.01% | 2018-09-30 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 294.10 tis | 0.37% | 0.09% | 0.57% | 2024-03-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 334.80 tis | 0.36% | 0.00% | 0.00% | 2020-06-30 |
| BRAUN STACEY ASSOCIATES INC | 324.81 tis | 0.35% | 0.39% | 0.39% | 2026-03-31 |
| CITADEL ADVISORS LLC | 317.93 tis | 0.34% | 0.00% | 0.00% | 2019-06-30 |
| VOYA INVESTMENT MANAGEMENT LLC | 306.04 tis | 0.33% | 0.00% | 0.01% | 2020-12-31 |
| MILLENNIUM MANAGEMENT LLC | 300.34 tis | 0.32% | 0.00% | 0.01% | 2025-03-31 |
| CORMORANT ASSET MANAGEMENT, LP | 300.00 tis | 0.32% | -0.50% | 0.65% | 2023-09-30 |
| OPALEYE MANAGEMENT INC. | 210.00 tis | 0.31% | -2.86% | 0.05% | 2019-03-31 |
| BARCLAYS PLC | 292.05 tis | 0.31% | 0.00% | 0.00% | 2018-09-30 |
| M&G PLC | 281.90 tis | 0.30% | 0.00% | 0.05% | 2025-03-31 |
| GHOST TREE CAPITAL, LLC | 200.00 tis | 0.30% | 1.84% | 2.59% | 2023-09-30 |
| ENSIGN PEAK ADVISORS, INC | 275.62 tis | 0.29% | 0.00% | 0.02% | 2021-09-30 |
| TD ASSET MANAGEMENT INC | 205.00 tis | 0.28% | 0.00% | 0.01% | 2023-03-31 |
| DEUTSCHE BANK AG\ | 203.89 tis | 0.28% | 0.00% | 0.00% | 2018-09-30 |
| VICTORY CAPITAL MANAGEMENT INC | 261.53 tis | 0.28% | 0.00% | 0.00% | 2023-09-30 |
| CHECKPOINT CAPITAL L.P. | 260.00 tis | 0.28% | 3.63% | 3.63% | 2025-09-30 |
| FIRST TRUST ADVISORS LP | 196.96 tis | 0.27% | 0.00% | 0.01% | 2023-12-31 |
| PRUDENTIAL FINANCIAL INC | 242.88 tis | 0.26% | -0.01% | 0.01% | 2023-06-30 |
| NEW YORK STATE COMMON RETIREMENT FUND | 166.74 tis | 0.23% | 0.00% | 0.01% | 2018-12-31 |
| MOODY ALDRICH PARTNERS LLC | 150.18 tis | 0.21% | 0.86% | 1.31% | 2023-09-30 |
| JEFFERIES FINANCIAL GROUP INC. | 150.00 tis | 0.21% | 0.07% | 0.07% | 2024-06-30 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 131.06 tis | 0.18% | 0.00% | 0.01% | 2020-06-30 |
| SWISS NATIONAL BANK | 130.30 tis | 0.18% | 0.00% | 0.00% | 2019-06-30 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 116.32 tis | 0.16% | 0.03% | 0.04% | 2023-03-31 |
| RHUMBLINE ADVISERS | 112.32 tis | 0.16% | 0.00% | 0.00% | 2018-12-31 |
| RAFFERTY ASSET MANAGEMENT, LLC | 112.17 tis | 0.16% | -0.02% | 0.02% | 2021-09-30 |
| PIER CAPITAL, LLC | 108.55 tis | 0.15% | -0.03% | 0.72% | 2023-12-31 |
| RUSSELL INVESTMENTS GROUP, LTD. | 102.39 tis | 0.14% | 0.00% | 0.01% | 2023-09-30 |
| LISANTI CAPITAL GROWTH, LLC | 83.38 tis | 0.12% | 0.11% | 0.90% | 2023-09-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 9624 | 20.02 | 10.4 2026 | 10589 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 49474 | 23.98 | 10.4 2026 | 63027 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 19336 | 19.64 | 10.4 2026 | 65977 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | S-Sale | 85163 | 40.10 | 10.4 2026 | 105289 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 49474 | 23.98 | 10.4 2026 | 161492 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 9624 | 20.02 | 10.4 2026 | 171116 |
| Knight Jeff E. | officer: Chief Dev. & Operating Officer | M-Exempt | 19336 | 19.64 | 10.4 2026 | 190452 |
| Struthers Richard Scott | director, officer: President & CEO | S-Sale | 8785 | 37.77 | 18.3 2026 | 404778 |
| Struthers Richard Scott | director, officer: President & CEO | S-Sale | 13196 | 37.11 | 18.3 2026 | 413563 |
| Betz Stephen F. | officer: Chief Scientific Officer | S-Sale | 4241 | 37.77 | 18.3 2026 | 137101 |
| Betz Stephen F. | officer: Chief Scientific Officer | S-Sale | 6371 | 37.11 | 18.3 2026 | 141342 |
| Knight Jeff E. | officer: Chief Operating Officer | S-Sale | 3961 | 37.77 | 18.3 2026 | 112018 |
| Knight Jeff E. | officer: Chief Operating Officer | S-Sale | 5950 | 37.11 | 18.3 2026 | 115979 |
| Vivaldi Coelho Rogerio | director | S-Sale | 523 | 36.77 | 13.3 2026 | 16300 |
| Vivaldi Coelho Rogerio | director | S-Sale | 4477 | 36.08 | 13.3 2026 | 16823 |
| Schilke Tobin | officer: Chief Financial Officer | S-Sale | 6713 | 39.67 | 4.3 2026 | 78121 |
| Okey Stephanie | director | S-Sale | 3000 | 39.67 | 4.3 2026 | 13300 |
| Kalofonos Isabel | officer: Chief Commercial Officer | A-Award | 34000 | 0.00 | 25.2 2026 | 34834 |
| Kalofonos Isabel | officer: Chief Commercial Officer | A-Award | 55000 | 43.79 | 25.2 2026 | 55000 |
| Betz Stephen F. | officer: Chief Scientific Officer | A-Award | 47000 | 43.79 | 25.2 2026 | 47000 |
| Betz Stephen F. | officer: Chief Scientific Officer | A-Award | 30000 | 0.00 | 25.2 2026 | 147713 |
| Knight Jeff E. | officer: Chief Operating Officer | A-Award | 55000 | 43.79 | 25.2 2026 | 55000 |
| Knight Jeff E. | officer: Chief Operating Officer | A-Award | 34000 | 0.00 | 25.2 2026 | 121929 |
| Schilke Tobin | officer: Chief Financial Officer | A-Award | 50000 | 43.79 | 25.2 2026 | 50000 |
| Schilke Tobin | officer: Chief Financial Officer | A-Award | 32000 | 0.00 | 25.2 2026 | 84834 |
| Struthers Richard Scott | director, officer: President & CEO | A-Award | 228000 | 43.79 | 25.2 2026 | 228000 |
| Struthers Richard Scott | director, officer: President & CEO | A-Award | 62000 | 0.00 | 25.2 2026 | 426759 |
| Kalofonos Isabel | officer: Chief Commercial Officer | S-Sale | 2500 | 55.00 | 7.1 2026 | 834 |
| Kalofonos Isabel | officer: Chief Commercial Officer | M-Exempt | 2500 | 40.59 | 7.1 2026 | 3334 |
| Kalofonos Isabel | officer: Chief Commercial Officer | M-Exempt | 2500 | 40.59 | 7.1 2026 | 97500 |
| Betz Stephen F. | officer: Chief Scientific Officer | M-Exempt | 18000 | 1.91 | 29.12 2025 | 90514 |
| Betz Stephen F. | officer: Chief Scientific Officer | M-Exempt | 18000 | 1.91 | 29.12 2025 | 117713 |
| Struthers Richard Scott | director, officer: President & CEO | M-Exempt | 16342 | 9.28 | 18.12 2025 | 0 |
| Struthers Richard Scott | director, officer: President & CEO | M-Exempt | 28400 | 15.29 | 18.12 2025 | 259058 |
| Struthers Richard Scott | director, officer: President & CEO | M-Exempt | 16342 | 9.28 | 18.12 2025 | 336359 |
| Struthers Richard Scott | director, officer: President & CEO | M-Exempt | 28400 | 15.29 | 18.12 2025 | 364759 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 5000 | 45.02 | 3.12 2025 | 66837 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 3.12 2025 | 69042 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 3.12 2025 | 71837 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 100 | 43.27 | 5.11 2025 | 66270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 4900 | 42.65 | 5.11 2025 | 66370 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 5.11 2025 | 71270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 5.11 2025 | 74042 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 5000 | 41.81 | 3.10 2025 | 66270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 3.10 2025 | 71270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 3.10 2025 | 79042 |
| Fust Matthew K | director | M-Exempt | 10000 | 1.91 | 30.9 2025 | 2092 |
| Fust Matthew K | director | S-Sale | 16000 | 44.75 | 30.9 2025 | 22836 |
| Fust Matthew K | director | M-Exempt | 10000 | 1.91 | 30.9 2025 | 38836 |
| Struthers Richard Scott | director, officer: President & CEO | S-Sale | 4000 | 45.00 | 30.9 2025 | 106000 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 4.9 2025 | 84042 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 5000 | 32.10 | 4.9 2025 | 96270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 4.9 2025 | 101270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 30000 | 30.43 | 26.8 2025 | 66270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 30000 | 16.89 | 26.8 2025 | 89042 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 30000 | 16.89 | 26.8 2025 | 96270 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 6492 | 29.18 | 21.8 2025 | 66270 |
| Betz Stephen F. | officer: Chief Scientific Officer | M-Exempt | 16645 | 9.28 | 16.6 2025 | 58198 |
| Betz Stephen F. | officer: Chief Scientific Officer | S-Sale | 97483 | 32.23 | 16.6 2025 | 99713 |
| Betz Stephen F. | officer: Chief Scientific Officer | M-Exempt | 71525 | 1.91 | 16.6 2025 | 108514 |
| Betz Stephen F. | officer: Chief Scientific Officer | M-Exempt | 71525 | 1.91 | 16.6 2025 | 180551 |
| Betz Stephen F. | officer: Chief Scientific Officer | M-Exempt | 16645 | 9.28 | 16.6 2025 | 197196 |
| WIERENGA WENDALL | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| WIERENGA WENDALL | director | A-Award | 6900 | 0.00 | 13.6 2025 | 116146 |
| Nichols Weston | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| Nichols Weston | director | A-Award | 6900 | 0.00 | 13.6 2025 | 16300 |
| Bedrosian Camille L | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| Bedrosian Camille L | director | A-Award | 6900 | 0.00 | 13.6 2025 | 16300 |
| Fust Matthew K | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| Fust Matthew K | director | A-Award | 6900 | 0.00 | 13.6 2025 | 28836 |
| Vivaldi Coelho Rogerio | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| Vivaldi Coelho Rogerio | director | A-Award | 6900 | 0.00 | 13.6 2025 | 21300 |
| Okey Stephanie | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| Deardorf Caren | director | A-Award | 10350 | 32.33 | 13.6 2025 | 10350 |
| Deardorf Caren | director | A-Award | 6900 | 0.00 | 13.6 2025 | 16300 |
| Okey Stephanie | director | A-Award | 6900 | 0.00 | 13.6 2025 | 16300 |
| Struthers Richard Scott | director, officer: President & CEO | G-Gift | 90400 | 0.00 | 16.5 2025 | 320017 |
| Struthers Richard Scott | director, officer: President & CEO | G-Gift | 90400 | 0.00 | 16.5 2025 | 661205 |
| Struthers Richard Scott | director, officer: President & CEO | M-Exempt | 81270 | 1.91 | 4.4 2025 | 0 |
| Struthers Richard Scott | director, officer: President & CEO | M-Exempt | 81270 | 1.91 | 4.4 2025 | 410417 |
| Struthers Richard Scott | director, officer: President & CEO | S-Sale | 875 | 34.83 | 21.3 2025 | 329147 |
| Struthers Richard Scott | director, officer: President & CEO | S-Sale | 16463 | 34.17 | 21.3 2025 | 330022 |
| Betz Stephen F. | officer: Chief Scientific Officer | S-Sale | 291 | 34.83 | 21.3 2025 | 108588 |
| Betz Stephen F. | officer: Chief Scientific Officer | S-Sale | 5479 | 34.17 | 21.3 2025 | 108879 |
| Knight Jeff E. | officer: Chief Operating Officer | S-Sale | 361 | 34.83 | 21.3 2025 | 87491 |
| Knight Jeff E. | officer: Chief Operating Officer | S-Sale | 6801 | 34.17 | 21.3 2025 | 87852 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 127 | 34.83 | 21.3 2025 | 72233 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | S-Sale | 2388 | 34.17 | 21.3 2025 | 72360 |
| Schilke Tobin | officer: Chief Financial Officer | A-Award | 52000 | 0.00 | 11.3 2025 | 52000 |
| Schilke Tobin | officer: Chief Financial Officer | A-Award | 80000 | 33.75 | 11.3 2025 | 80000 |
| Schilke Tobin | 0 | 0.00 | 5.3 2025 | 0 | ||
| Betz Stephen F. | officer: Chief Scientific Officer | A-Award | 65000 | 36.86 | 24.2 2025 | 65000 |
| Betz Stephen F. | officer: Chief Scientific Officer | A-Award | 43000 | 0.00 | 24.2 2025 | 114358 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | A-Award | 65000 | 36.86 | 24.2 2025 | 65000 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | A-Award | 43000 | 0.00 | 24.2 2025 | 74748 |
| Knight Jeff E. | officer: Chief Operating Officer | A-Award | 65000 | 36.86 | 24.2 2025 | 65000 |
| Knight Jeff E. | officer: Chief Operating Officer | A-Award | 43000 | 0.00 | 24.2 2025 | 94653 |
| Struthers Richard Scott | director, officer: President & CEO | A-Award | 313000 | 36.86 | 24.2 2025 | 313000 |
| Struthers Richard Scott | director, officer: President & CEO | A-Award | 89000 | 0.00 | 24.2 2025 | 346485 |
| Pizzuti Dana | officer: Chief Med and Dev Officer | M-Exempt | 5000 | 16.89 | 5.2 2025 | 119042 |
